1 – 50 of 144
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories : a systematic analysis for the Global Burden of Disease Study 2017
- Contribution to journal › Article
-
Mark
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017 : a systematic analysis for the Global Burden of Disease Study 2017
- Contribution to journal › Article
-
Mark
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017 : a systematic analysis for the Global Burden of Disease Study 2017
(
- Contribution to journal › Article
-
Mark
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017 : a systematic analysis for the Global Burden of Disease Study 2017
- Contribution to journal › Article
-
Mark
Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017 : a systematic analysis for the Global Burden of Disease Study 2017
- Contribution to journal › Article
-
Mark
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017 : a systematic analysis for the Global Burden of Disease Study 2017
- Contribution to journal › Article
-
Mark
Spending on health and HIV/AIDS : domestic health spending and development assistance in 188 countries, 1995-2015
(
- Contribution to journal › Article
-
Mark
Trends in future health financing and coverage : future health spending and universal health coverage in 188 countries, 2016-40
(
- Contribution to journal › Article
-
Mark
Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations : a systematic analysis from the Global Burden of Disease Study 2016
(
- Contribution to journal › Article
- 2017
-
Mark
Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015 : a novel analysis from the Global Burden of Disease Study 2015
(
- Contribution to journal › Article
-
Mark
Future and potential spending on health 2015-40 : development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries
(
- Contribution to journal › Article
-
Mark
Evolution and patterns of global health financing 1995-2014 : development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries
(
- Contribution to journal › Article
-
Mark
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016 : a systematic analysis for the Global Burden of Disease Study 2016
(
- Contribution to journal › Article
-
Mark
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016 : a systematic analysis for the Global Burden of Disease Study 2016
(
- Contribution to journal › Article
-
Mark
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016 : a systematic analysis for the Global Burden of Disease Study 2016
(
- Contribution to journal › Article
-
Mark
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016 : a systematic analysis for the Global Burden of Disease Study 2016
(
- Contribution to journal › Article
-
Mark
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016 : a systematic analysis for the Global Burden of Disease Study 2016
(
- Contribution to journal › Article
-
Mark
Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries : an analysis from the Global Burden of Disease Study 2016
(
- Contribution to journal › Article
- 2016
-
Mark
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study.
(
- Contribution to journal › Article
-
Mark
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015 : a systematic analysis for the Global Burden of Disease Study 2015
(
- Contribution to journal › Article
-
Mark
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015 : the Global Burden of Disease Study 2015
- Contribution to journal › Article
- 2015
-
Mark
Genetics and neonatal diabetes: towards precision medicine.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials.
(
- Contribution to journal › Article
-
Mark
Letter from the future surgeons of 2030
(
- Contribution to journal › Letter
-
Mark
Glaucoma treatment: by the highest level of evidence.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition
(
- Contribution to journal › Article
-
Mark
Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
(
- Contribution to journal › Article
-
Mark
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
(
- Contribution to journal › Article
-
Mark
Who is performing surgery in low-income settings: a countrywide inventory of the surgical workforce distribution and scope of practice in Sierra Leone.
(
- Contribution to journal › Article
-
Mark
Towards closing the gap of the global surgeon, anaesthesiologist, and obstetrician workforce: thresholds and projections towards 2030.
(
- Contribution to journal › Article
-
Mark
Generation of national political priority for surgery: a qualitative case study of three low-income and middle-income countries.
(
- Contribution to journal › Article
-
Mark
Surgical care by non-surgeons in low-income and middle-income countries: a systematic review.
(
- Contribution to journal › Article
-
Mark
Monitoring and evaluating surgical care: defining perioperative mortality rate and standardising data collection.
(
- Contribution to journal › Article
-
Mark
Use and definitions of perioperative mortality rates in low-income and middle-income countries : a systematic review
(
- Contribution to journal › Published meeting abstract
-
Mark
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
(
- Contribution to journal › Article
-
Mark
How much donor financing for health is channelled to global versus country-specific aid functions?
(
- Contribution to journal › Article
-
Mark
Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001) : an open-label, non-inferiority, randomised controlled trial
(
- Contribution to journal › Article
-
Mark
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1 : a substudy of the NEAT001/ANRS143 randomised trial
(
- Contribution to journal › Article
-
Mark
Global surveillance of cancer survival 1995-2009 : analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)
(
- Contribution to journal › Article
-
Mark
Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development.
(
- Contribution to journal › Scientific review
-
Mark
Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies
(
- Contribution to journal › Article
-
Mark
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
(
- Contribution to journal › Article
- 2014
-
Mark
Country experience with strengthening of health systems and deployment of midwives in countries with high maternal mortality.
(
- Contribution to journal › Article
-
Mark
Surgery and global health: a Lancet Commission.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Global surgery: defining an emerging global health field.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Hospital contacts for endocrine disorders in Adult Life after Childhood Cancer in Scandinavia (ALiCCS): a population-based cohort study.
(
- Contribution to journal › Article
-
Mark
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
(
- Contribution to journal › Article
-
Mark
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease : a dose escalation, open-label, phase 1/2 trial
(
- Contribution to journal › Article
-
Mark
Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1 : 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial
(
- Contribution to journal › Article
-
Mark
The many faces of diabetes: a disease with increasing heterogeneity
(
- Contribution to journal › Scientific review